Literature DB >> 29885986

Clinical, electrophysiological, and imaging study in essential tremor-Parkinson's disease syndrome.

Gennarina Arabia1, Angela Lupo1, Lucia Ilaria Manfredini1, Basilio Vescio2, Rita Nisticò3, Gaetano Barbagallo1, Maria Salsone3, Maurizio Morelli1, Fabiana Novellino3, Giuseppe Nicoletti3, Andrea Quattrone1, Giuseppe Lucio Cascini4, Elan D Louis5, Aldo Quattrone6.   

Abstract

INTRODUCTION: Essential tremor-Parkinson's disease (ET-PD) syndrome is a clinical condition in which individuals with a long-lasting history of Essential tremor (ET) eventually develop Parkinson's disease (PD). The aim of the study was to investigate the accuracy performances of clinical, neurophysiological, and imaging biomarkers in differentiating patients affected by ET-PD syndrome from patients with ET or PD.
METHODS: Nineteen patients affected by ET-PD syndrome, 48 ET patients, and 37 tremor-dominant PD (t-PD) patients were included. Electrophysiological studies, including blink-reflex recovery cycle and tremor parameters analyses, were performed in all groups. Nigro-striatal and cardiac sympathetic denervation were also investigated. Sensitivity, specificity and accuracy of clinical, electrophysiological, and radiological features in differentiating ET-PD syndrome from ET and PD were calculated.
RESULTS: ET-PD patients had significantly lower rigidity (p = 0.007) and higher postural/kinetic tremor (p = 0.007) scores, in comparison to t-PD patients. ET-PD patients, differently from PD patients, had a synchronous pattern of resting tremor and, differently from ET patients, had abnormal blink-reflex recovery cycle. ET-PD patients also showed reduced nigro-striatal and cardiac sympathetic uptakes, albeit to a lesser extent than in PD patients. The highest accuracy values were found for the synchronous pattern of resting tremor (97.1%) in distinguishing ET-PD from PD, and for presence of abnormal blink-recovery cycle (100%) in distinguishing ET-PD syndrome from ET.
CONCLUSION: Our study demonstrates that some electrophysiological parameters, such as a synchronous resting tremor pattern and the abnormal blink-recovery cycle were the most accurate biomarkers in distinguishing patient with ET-PD syndrome from those with ET or those with PD.
Copyright © 2018. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2018        PMID: 29885986     DOI: 10.1016/j.parkreldis.2018.06.005

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  5 in total

1.  Evaluation of rest tremor in different positions in Parkinson's disease and essential tremor plus.

Authors:  Rita Nisticò; Andrea Quattrone; Marianna Crasà; Marida De Maria; Basilio Vescio; Aldo Quattrone
Journal:  Neurol Sci       Date:  2022-01-15       Impact factor: 3.307

2.  Rest Tremor Pattern Predicts DaTscan (123 I-Ioflupane) Result in Tremulous Disorders.

Authors:  Andrea Quattrone; Rita Nisticò; Maurizio Morelli; Gennarina Arabia; Marianna Crasà; Basilio Vescio; Alessandro Mechelli; Giuseppe L Cascini; Aldo Quattrone
Journal:  Mov Disord       Date:  2021-09-28       Impact factor: 9.698

3.  Association between positive history of essential tremor and disease progression in patients with Parkinson's disease.

Authors:  Ruwei Ou; Qianqian Wei; Yanbing Hou; Lingyu Zhang; Kuncheng Liu; Junyu Lin; Zheng Jiang; Wei Song; Bei Cao; Huifang Shang
Journal:  Sci Rep       Date:  2020-12-10       Impact factor: 4.379

4.  Blink reflex recovery cycle distinguishes patients with idiopathic normal pressure hydrocephalus from elderly subjects.

Authors:  Alessandro Mechelli; Andrea Quattrone; Rita Nisticò; Marianna Crasà; Domenico La Torre; Basilio Vescio; Aldo Quattrone
Journal:  J Neurol       Date:  2021-07-02       Impact factor: 6.682

5.  Clinical Characteristics and Electrophysiological Biomarkers of Parkinson's Disease Developed From Essential Tremor.

Authors:  Xuemei Wang; Zhentang Cao; Genliang Liu; Zhu Liu; Ying Jiang; Huizi Ma; Zhan Wang; Yaqin Yang; Huimin Chen; Tao Feng
Journal:  Front Neurol       Date:  2020-10-29       Impact factor: 4.003

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.